Cargando…

Glaucoma surgery during the first year of the COVID-19 pandemic

PURPOSE: To summarize the actions taken to give continuity to the surgical treatment of glaucoma patients and to present the volume and characteristics of glaucoma surgery in the first year of pandemic at the Tertiary Glaucoma Center of the University Hospital of Verona (Veneto, Italy). METHODS: Dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Rosa, Franzolin, Elia, Pedrotti, Emilio, Fasolo, Adriano, Bonacci, Erika, Marchini, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013211/
https://www.ncbi.nlm.nih.gov/pubmed/35430683
http://dx.doi.org/10.1007/s10792-022-02278-6
_version_ 1784687950155481088
author Longo, Rosa
Franzolin, Elia
Pedrotti, Emilio
Fasolo, Adriano
Bonacci, Erika
Marchini, Giorgio
author_facet Longo, Rosa
Franzolin, Elia
Pedrotti, Emilio
Fasolo, Adriano
Bonacci, Erika
Marchini, Giorgio
author_sort Longo, Rosa
collection PubMed
description PURPOSE: To summarize the actions taken to give continuity to the surgical treatment of glaucoma patients and to present the volume and characteristics of glaucoma surgery in the first year of pandemic at the Tertiary Glaucoma Center of the University Hospital of Verona (Veneto, Italy). METHODS: Demographical and surgical features of patients who underwent glaucoma surgery from March 9th, 2020 to March 8th, 2021 have been collected and compared to the same date range of the previous year. The analyzed data included age, gender, region of origin, glaucoma staging, type of anesthesia and surgical procedure. RESULTS: The surgical volume of glaucoma has dropped by 30.1%. In comparison with the previous year, we found a significant variation in the overall distribution of the performed surgical procedures (p < 0.001). There was a decline in Baerveldt tube implants (− 4.9%), and an increase of non-penetrating surgery (+ 2.6%), cyclo-photo ablative procedures (+ 4.2%) and MIGS (+ 5.7%). Only 24.3% of the procedures were performed under general anesthesia compared to 41.5% in the pre-pandemic period (p < 0.001). The number of procedures performed on eyes affected by advanced or end-stage glaucoma is doubled (p < 0.001). CONCLUSIONS: To give continuity to glaucoma surgery, we prioritized interventions on patients with poorer visual fields, rapidly progressing visual field deficit and elevated IOP uncontrolled by maximal medical therapy. Secondly, we have rescheduled the other interventions following the same priority criteria. Finally, we managed some lower priority cases with MIGS, minimizing the need for close post-intervention follow-up. Considering the negative consequences that a delay in the management of glaucoma can have in terms of visual loss, the closure of the operating rooms in the first quarter of the pandemic was detrimental. It appears that glaucoma surgery deserves urgencies that cannot be overshadowed and the greatest effort must be to give continuity to this type of eye surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10792-022-02278-6.
format Online
Article
Text
id pubmed-9013211
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-90132112022-04-18 Glaucoma surgery during the first year of the COVID-19 pandemic Longo, Rosa Franzolin, Elia Pedrotti, Emilio Fasolo, Adriano Bonacci, Erika Marchini, Giorgio Int Ophthalmol Original Paper PURPOSE: To summarize the actions taken to give continuity to the surgical treatment of glaucoma patients and to present the volume and characteristics of glaucoma surgery in the first year of pandemic at the Tertiary Glaucoma Center of the University Hospital of Verona (Veneto, Italy). METHODS: Demographical and surgical features of patients who underwent glaucoma surgery from March 9th, 2020 to March 8th, 2021 have been collected and compared to the same date range of the previous year. The analyzed data included age, gender, region of origin, glaucoma staging, type of anesthesia and surgical procedure. RESULTS: The surgical volume of glaucoma has dropped by 30.1%. In comparison with the previous year, we found a significant variation in the overall distribution of the performed surgical procedures (p < 0.001). There was a decline in Baerveldt tube implants (− 4.9%), and an increase of non-penetrating surgery (+ 2.6%), cyclo-photo ablative procedures (+ 4.2%) and MIGS (+ 5.7%). Only 24.3% of the procedures were performed under general anesthesia compared to 41.5% in the pre-pandemic period (p < 0.001). The number of procedures performed on eyes affected by advanced or end-stage glaucoma is doubled (p < 0.001). CONCLUSIONS: To give continuity to glaucoma surgery, we prioritized interventions on patients with poorer visual fields, rapidly progressing visual field deficit and elevated IOP uncontrolled by maximal medical therapy. Secondly, we have rescheduled the other interventions following the same priority criteria. Finally, we managed some lower priority cases with MIGS, minimizing the need for close post-intervention follow-up. Considering the negative consequences that a delay in the management of glaucoma can have in terms of visual loss, the closure of the operating rooms in the first quarter of the pandemic was detrimental. It appears that glaucoma surgery deserves urgencies that cannot be overshadowed and the greatest effort must be to give continuity to this type of eye surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10792-022-02278-6. Springer Netherlands 2022-04-16 2022 /pmc/articles/PMC9013211/ /pubmed/35430683 http://dx.doi.org/10.1007/s10792-022-02278-6 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Longo, Rosa
Franzolin, Elia
Pedrotti, Emilio
Fasolo, Adriano
Bonacci, Erika
Marchini, Giorgio
Glaucoma surgery during the first year of the COVID-19 pandemic
title Glaucoma surgery during the first year of the COVID-19 pandemic
title_full Glaucoma surgery during the first year of the COVID-19 pandemic
title_fullStr Glaucoma surgery during the first year of the COVID-19 pandemic
title_full_unstemmed Glaucoma surgery during the first year of the COVID-19 pandemic
title_short Glaucoma surgery during the first year of the COVID-19 pandemic
title_sort glaucoma surgery during the first year of the covid-19 pandemic
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013211/
https://www.ncbi.nlm.nih.gov/pubmed/35430683
http://dx.doi.org/10.1007/s10792-022-02278-6
work_keys_str_mv AT longorosa glaucomasurgeryduringthefirstyearofthecovid19pandemic
AT franzolinelia glaucomasurgeryduringthefirstyearofthecovid19pandemic
AT pedrottiemilio glaucomasurgeryduringthefirstyearofthecovid19pandemic
AT fasoloadriano glaucomasurgeryduringthefirstyearofthecovid19pandemic
AT bonaccierika glaucomasurgeryduringthefirstyearofthecovid19pandemic
AT marchinigiorgio glaucomasurgeryduringthefirstyearofthecovid19pandemic